Condition or disease | Intervention/treatment | Phase |
---|---|---|
Vaping Cessation, Tobacco | Behavioral: This is Quitting Other: Assessment only control | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 3000 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Double (Participant, Outcomes Assessor) |
Masking Description: | Participants are not explicitly told they are in the control group, although they may deduce their assignment from presence or lack of regular text message intervention. Research staff doing data collection will not be aware of the random assignments and all participants will receive the same follow-up assessments regardless of assignment. |
Primary Purpose: | Treatment |
Official Title: | Text Message Quit Vaping Intervention for Adolescents |
Actual Study Start Date : | October 1, 2021 |
Estimated Primary Completion Date : | October 31, 2022 |
Estimated Study Completion Date : | October 31, 2022 |
Arm | Intervention/treatment |
---|---|
Experimental: This is Quitting
Participants will be enrolled to receive messages from This is Quitting. Users receive one age-appropriate message per day tailored to their enrollment date or quit date, which can be set and reset via text message. Those not ready to quit receive 4 weeks of messages focused on building skills and confidence. Users who set a quit date receive messages for a week preceding it and 8 weeks afterward that include encouragement and support, skill- and self-efficacy building exercises, coping strategies, and information about the risks of vaping, benefits of quitting, and cutting down to quit. Keywords COPE, STRESS, SLIP, and MORE provide on-demand support. |
Behavioral: This is Quitting
Text message-based intervention for quit vaping support.
|
Assessment only control
After an initial enrollment message, participants will be contacted monthly to assess e-cigarette use. At the end of the study data collection period, they will receive information on how to sign up for This is Quitting if they are interested in the program.
|
Other: Assessment only control
Assessment only
|
No Intervention: Minimal contact control
After an initial enrollment message, participants will not receive any contact except for the data collection for 1 and 7 month follow-up assessments. At the end of the study data collection period, they will receive information on how to sign up for This is Quitting if they are interested in the program.
|
Ages Eligible for Study: | 13 Years to 17 Years (Child) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
Contact: Chief of Innovations | 202-525-6473 | vapestudy@truthinitiative.org |
United States, District of Columbia | |
Truth Initiative | Recruiting |
Washington, District of Columbia, United States, 20001 |
Tracking Information | |||||
---|---|---|---|---|---|
First Submitted Date ICMJE | June 4, 2021 | ||||
First Posted Date ICMJE | June 9, 2021 | ||||
Last Update Posted Date | October 25, 2021 | ||||
Actual Study Start Date ICMJE | October 1, 2021 | ||||
Estimated Primary Completion Date | October 31, 2022 (Final data collection date for primary outcome measure) | ||||
Current Primary Outcome Measures ICMJE |
Self-reported 30-day Point Prevalence Abstinence [ Time Frame: 7 months post enrollment ] In the past 30 days, did you vape at all, even a puff of someone else's?
|
||||
Original Primary Outcome Measures ICMJE | Same as current | ||||
Change History | |||||
Current Secondary Outcome Measures ICMJE |
|
||||
Original Secondary Outcome Measures ICMJE |
|
||||
Current Other Pre-specified Outcome Measures | Not Provided | ||||
Original Other Pre-specified Outcome Measures | Not Provided | ||||
Descriptive Information | |||||
Brief Title ICMJE | Text Message Quit Vaping Intervention for Adolescents | ||||
Official Title ICMJE | Text Message Quit Vaping Intervention for Adolescents | ||||
Brief Summary | This research study, conducted by Truth Initiative, will help us learn how text messaging can help adolescents between 13 and 17 years of age quit vaping. | ||||
Detailed Description | The Teen Quit Vaping Study (QVS Teen)'s primary aim is to conduct a fully powered comparative effectiveness trial to evaluate the effectiveness of a quit vaping text message program in promoting abstinence from e-cigarettes among young users aged 13-17. This study is a 3-arm randomized controlled trial conducted among young users aged 13-17 recruited through online channels. Participants will be randomized to a quit vaping text message intervention, an assessment-only control condition, and a minimal contact control condition and followed for 7 months to roughly correspond to 6-months post-treatment. The secondary aim is to examine potential mediators of program effectiveness, including treatment engagement and changes in self-efficacy and perceived social support for quitting. | ||||
Study Type ICMJE | Interventional | ||||
Study Phase ICMJE | Not Applicable | ||||
Study Design ICMJE | Allocation: Randomized Intervention Model: Parallel Assignment Masking: Double (Participant, Outcomes Assessor) Masking Description: Participants are not explicitly told they are in the control group, although they may deduce their assignment from presence or lack of regular text message intervention. Research staff doing data collection will not be aware of the random assignments and all participants will receive the same follow-up assessments regardless of assignment. |
||||
Condition ICMJE |
|
||||
Intervention ICMJE |
|
||||
Study Arms ICMJE |
|
||||
Publications * | Not Provided | ||||
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||
Recruitment Information | |||||
Recruitment Status ICMJE | Recruiting | ||||
Estimated Enrollment ICMJE |
3000 | ||||
Original Estimated Enrollment ICMJE | Same as current | ||||
Estimated Study Completion Date ICMJE | October 31, 2022 | ||||
Estimated Primary Completion Date | October 31, 2022 (Final data collection date for primary outcome measure) | ||||
Eligibility Criteria ICMJE |
Inclusion Criteria:
Exclusion Criteria:
|
||||
Sex/Gender ICMJE |
|
||||
Ages ICMJE | 13 Years to 17 Years (Child) | ||||
Accepts Healthy Volunteers ICMJE | Yes | ||||
Contacts ICMJE |
|
||||
Listed Location Countries ICMJE | United States | ||||
Removed Location Countries | |||||
Administrative Information | |||||
NCT Number ICMJE | NCT04919590 | ||||
Other Study ID Numbers ICMJE | TruthInitiativeQVSTeen | ||||
Has Data Monitoring Committee | Yes | ||||
U.S. FDA-regulated Product |
|
||||
IPD Sharing Statement ICMJE |
|
||||
Responsible Party | Truth Initiative | ||||
Study Sponsor ICMJE | Truth Initiative | ||||
Collaborators ICMJE | Not Provided | ||||
Investigators ICMJE | Not Provided | ||||
PRS Account | Truth Initiative | ||||
Verification Date | October 2021 | ||||
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |